Through their partnership, Genomenon and Veritas Genetics hope to develop a new literature prioritization engine to bring down the cost of WGS interpretation.
The firm said it will use the funding to consolidate its position in clinical diagnostics, establish a US office, and enter new diagnostic markets.
As part of a collaboration with Freenome, Institut Curie will look for correlations between circulating biomarkers and human response to cancer immunotherapies.
As genomics increasingly becomes a part of healthcare, more diverse datasets will be needed to avoid biases in algorithms used to analyze data and make diagnoses.
At HIMSS18, Eric Schmidt announced a new healthcare API for Google Cloud and explored how predictive analytics might change medical care and research for the better.
The Israeli molecular diagnostics company will use artificial intelligence and phenotypic analysis to increase the diagnostic rate of its genetic tests.
Startup Optra Health has added Alexa and Cortana compatibility to its AI platform to help consumers understand Ancestry.com- and 23andMe-type genetic tests.
The latest release of Sophia AI merges imaging analysis with genomic medicine in pursuit of better diagnosis and treatment.
The company has also developed two liquid biopsy cancer test, Liquid GPS Core for DNA and Liquid GPS Expression for RNA.
Sophia Genetics has received a CE-IVD mark for a sequencing-based test that, combined with data analytics, is meant to improve detection of leukemia.
NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.
According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.
A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.
In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.